Grb7 SH2 domain structure and interactions with a cyclic peptide inhibitor of cancer cell migration and proliferation

[1]  T. Pawson,et al.  The SH2 Domain: A Prototype for Protein Interaction Modules , 2008 .

[2]  D. Krag,et al.  Combination treatment with Grb7 peptide and Doxorubicin or Trastuzumab (Herceptin) results in cooperative cell growth inhibition in breast cancer cells , 2007, British Journal of Cancer.

[3]  E. Raymond,et al.  New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors. , 2006, Seminars in oncology.

[4]  D. Krag,et al.  Specific peptide ligand for Grb7 signal transduction protein and pancreatic cancer metastasis. , 2006, Journal of the National Cancer Institute.

[5]  S. Hubbard,et al.  Structural basis for inhibition of the insulin receptor by the adaptor protein Grb14. , 2005, Molecular cell.

[6]  Neil O. Carragher,et al.  The role of focal-adhesion kinase in cancer — a new therapeutic opportunity , 2005, Nature Reviews Cancer.

[7]  A. Wakeling,et al.  Inhibitors of growth factor signalling. , 2005, Endocrine-related cancer.

[8]  E. Guth,et al.  Backbone nuclear relaxation characteristics and calorimetric investigation of the human Grb7‐SH2/erbB2 peptide complex , 2005, Protein science : a publication of the Protein Society.

[9]  K. Siddle,et al.  Grb10 and Grb14: enigmatic regulators of insulin action--and more? , 2005, The Biochemical journal.

[10]  J. Mackay,et al.  Grb7-SH2 domain dimerisation is affected by a single point mutation , 2005, European Biophysics Journal.

[11]  R. Daly,et al.  Adapter protein connections: The MRL and Grb7 protein families , 2005, Growth factors.

[12]  Anastassis Perrakis,et al.  Developments in the CCP4 molecular-graphics project. , 2004, Acta crystallographica. Section D, Biological crystallography.

[13]  R. Mariuzza,et al.  Structural basis for differential recognition of tyrosine‐phosphorylated sites in the linker for activation of T cells (LAT) by the adaptor Gads , 2004, The EMBO journal.

[14]  Tony Pawson,et al.  Specificity in Signal Transduction From Phosphotyrosine-SH2 Domain Interactions to Complex Cellular Systems , 2004, Cell.

[15]  R. Daly,et al.  Solution structure of the human Grb7-SH2 domain/erbB2 peptide complex and structural basis for Grb7 binding to ErbB2 , 2003, Journal of biomolecular NMR.

[16]  Peter Briggs,et al.  A graphical user interface to the CCP4 program suite. , 2003, Acta crystallographica. Section D, Biological crystallography.

[17]  D. Krag,et al.  Grb7-based molecular therapeutics in cancer , 2003, Expert Reviews in Molecular Medicine.

[18]  S. Hubbard,et al.  Structural Basis for Dimerization of the Grb10 Src Homology 2 Domain , 2003, The Journal of Biological Chemistry.

[19]  P. Traxler,et al.  Tyrosine kinases as targets in cancer therapy – successes and failures , 2003, Expert opinion on therapeutic targets.

[20]  J. Guan,et al.  EphB1 Associates with Grb7 and Regulates Cell Migration* , 2002, The Journal of Biological Chemistry.

[21]  M. Ivancic,et al.  Letter to the Editor: Assignment of backbone 1H, 13C, and 15N resonances of human Grb7-SH2 domain in complex with a phosphorylated peptide ligand , 2002, Journal of biomolecular NMR.

[22]  D. Krag,et al.  Identification of Novel Non-phosphorylated Ligands, Which Bind Selectively to the SH2 Domain of Grb7* , 2002, The Journal of Biological Chemistry.

[23]  J. Girard,et al.  Inhibition of Insulin Receptor Catalytic Activity by the Molecular Adapter Grb14* , 2002, The Journal of Biological Chemistry.

[24]  B. Roques,et al.  Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor. , 2002, Journal of molecular biology.

[25]  J. Feldner,et al.  Cancer cell motility--on the road from c-erbB-2 receptor steered signaling to actin reorganization. , 2002, Experimental cell research.

[26]  J. Guan,et al.  The Grb7 family proteins: structure, interactions with other signaling molecules and potential cellular functions , 2001, Oncogene.

[27]  S. Hubbard,et al.  The BPS domain of Grb10 inhibits the catalytic activity of the insulin and IGF1 receptors , 2001, FEBS letters.

[28]  U. Günther,et al.  NMR structure of the N-SH2 of the p85 subunit of phosphoinositide 3-kinase complexed to a doubly phosphorylated peptide reveals a second phosphotyrosine binding site. , 2000, Biochemistry.

[29]  J. Guan,et al.  Role of Grb7 Targeting to Focal Contacts and Its Phosphorylation by Focal Adhesion Kinase in Regulation of Cell Migration* , 2000, The Journal of Biological Chemistry.

[30]  P. Maher,et al.  Association of Fibroblast Growth Factor Receptor 1 with the Adaptor Protein Grb14 , 2000, The Journal of Biological Chemistry.

[31]  K. Alitalo,et al.  Identification of Tek/Tie2 Binding Partners , 1999, The Journal of Biological Chemistry.

[32]  Youping Deng,et al.  Grb10, a Positive, Stimulatory Signaling Adapter in Platelet-Derived Growth Factor BB-, Insulin-Like Growth Factor I-, and Insulin-Mediated Mitogenesis , 1999, Molecular and Cellular Biology.

[33]  J. Guan,et al.  Association of Focal Adhesion Kinase with Grb7 and Its Role in Cell Migration* , 1999, The Journal of Biological Chemistry.

[34]  Laxmikant V. Kale,et al.  NAMD2: Greater Scalability for Parallel Molecular Dynamics , 1999 .

[35]  P. Ettmayer,et al.  Structural and conformational requirements for high-affinity binding to the SH2 domain of Grb2(1). , 1999, Journal of medicinal chemistry.

[36]  P. W. Janes,et al.  Analysis of Grb7 Recruitment by Heregulin-activated erbB Receptors Reveals a Novel Target Selectivity for erbB3* , 1998, The Journal of Biological Chemistry.

[37]  A. Vagin,et al.  MOLREP: an Automated Program for Molecular Replacement , 1997 .

[38]  M. Snow,et al.  Thermodynamic and structural analysis of phosphotyrosine polypeptide binding to Grb2-SH2. , 1997, Biochemistry.

[39]  V S Lamzin,et al.  wARP: improvement and extension of crystallographic phases by weighted averaging of multiple-refined dummy atomic models. , 1997, Acta crystallographica. Section D, Biological crystallography.

[40]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[41]  B. Margolis,et al.  C. elegans cell migration gene mig-10 shares similarities with a family of SH2 domain proteins and acts cell nonautonomously in excretory canal development. , 1997, Developmental biology.

[42]  P. W. Janes,et al.  Structural Determinants of the Interaction between the erbB2 Receptor and the Src Homology 2 Domain of Grb7* , 1997, The Journal of Biological Chemistry.

[43]  T. Sugimura,et al.  Molecular cloning of human GRB-7 co-amplified with CAB1 and c-ERBB-2 in primary gastric cancer. , 1997, Biochemical and biophysical research communications.

[44]  S. Shoelson,et al.  Human GRB-IRbeta/GRB10. Splice variants of an insulin and growth factor receptor-binding protein with PH and SH2 domains. , 1997, The Journal of biological chemistry.

[45]  C. Heldin,et al.  Grb7 is a Downstream Signaling Component of Platelet-derived Growth Factor α- and β-Receptors* , 1996, The Journal of Biological Chemistry.

[46]  D. Cerretti,et al.  Ligand Activation of ELK Receptor Tyrosine Kinase Promotes Its Association with Grb10 and Grb2 in Vascular Endothelial Cells* , 1996, The Journal of Biological Chemistry.

[47]  I. Campbell,et al.  Alternative modes of tyrosyl phosphopeptide binding to a Src family SH2 domain: implications for regulation of tyrosine kinase activity. , 1996, Biochemistry.

[48]  D. Erdmann,et al.  Structural basis for specificity of GRB2-SH2 revealed by a novel ligand binding mode , 1996, Nature Structural Biology.

[49]  G M Sanderson,et al.  Cloning and Characterization of GRB14, a Novel Member of the GRB7 Gene Family (*) , 1996, The Journal of Biological Chemistry.

[50]  C. Sander,et al.  Errors in protein structures , 1996, Nature.

[51]  F. Giorgino,et al.  Interaction between the Grb10 SH2 Domain and the Insulin Receptor Carboxyl Terminus (*) , 1996, The Journal of Biological Chemistry.

[52]  M. Zurini,et al.  Crystal structure of the SH2 domain from the adaptor protein SHC: a model for peptide binding based on X-ray and NMR data. , 1995, Journal of molecular biology.

[53]  T. Logan,et al.  Solution structure of the Shc SH2 domain complexed with a tyrosine-phosphorylated peptide from the T-cell receptor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[55]  P. D’Eustachio,et al.  The SH2 domain protein GRB‐7 is co‐amplified, overexpressed and in a tight complex with HER2 in breast cancer. , 1994, The EMBO journal.

[56]  D. Baltimore,et al.  Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides , 1993, Nature.

[57]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[58]  T. Pawson,et al.  SH2 domains recognize specific phosphopeptide sequences , 1993, Cell.

[59]  J. Kuriyan,et al.  Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: Crystal structures of the complexed and peptide-free forms , 1993, Cell.

[60]  S. Harrison,et al.  Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck , 1993, Nature.

[61]  V. Saudek,et al.  Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions , 1992, Journal of biomolecular NMR.

[62]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[63]  I. Campbell,et al.  Comparison of techniques for 1H-detected heteronuclear 1H15N Spectroscopy , 1990 .

[64]  L. Kay,et al.  Comparison of different modes of two-dimensional reverse-correlation NMR for the study of proteins , 1990 .

[65]  P. V. von Hippel,et al.  Calculation of protein extinction coefficients from amino acid sequence data. , 1989, Analytical biochemistry.

[66]  A. J. Shaka,et al.  Computer-optimized decoupling scheme for wideband applications and low-level operation , 1985 .

[67]  M L Johnson,et al.  Analysis of data from the analytical ultracentrifuge by nonlinear least-squares techniques. , 1981, Biophysical journal.

[68]  S. French,et al.  On the treatment of negative intensity observations , 1978 .

[69]  B. Lee,et al.  The interpretation of protein structures: estimation of static accessibility. , 1971, Journal of molecular biology.

[70]  D. A. Yphantis.  EQUILIBRIUM ULTRACENTRIFUGATION OF DILUTE SOLUTIONS. , 1964, Biochemistry.

[71]  J. Wilce,et al.  NMR analysis of G7-18NATE, a nonphosphorylated cyclic peptide inhibitor of the Grb7 adapter protein. , 2007, Biopolymers.

[72]  P. Roller,et al.  Development of non-phosphorylated cyclic thioether peptide binding to the Grb2-SH2 domain , 2006, Letters in Peptide Science.

[73]  K. Ryan,et al.  Intracellular signalling and cancer: complex pathways lead to multiple targets. , 2005, European journal of cancer.

[74]  Giovanni Cesareni,et al.  Modular protein domains , 2005 .

[75]  J. Guan,et al.  Grb7 in intracellular signaling and its role in cell regulation. , 2004, Frontiers in bioscience : a journal and virtual library.

[76]  Gabriel Waksman,et al.  Molecular recognition by SH2 domains. , 2002, Advances in protein chemistry.

[77]  G M Clore,et al.  An efficient and cost-effective isotope labeling protocol for proteins expressed in shape Escherichia coli , 1998, Journal of biomolecular NMR.

[78]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[79]  K. Mafune,et al.  Coexpression of Grb7 with epidermal growth factor receptor or Her2/erbB2 in human advanced esophageal carcinoma. , 1997, Cancer research.

[80]  H. Rink.  Solid-phase synthesis of protected peptide fragments using a trialkoxy-diphenyl-methylester resin. , 1987 .